Ubigene

[Research highlight] Ubigene provides CRISPR lentivirus to facilitate Non-invasive diagnosis of BLCA-

pubdate：2022-09-27

[Research highlight] Ubigene provides CRISPR lentivirus to facilitate Non-invasive diagnosis of BLCA ...

NLRP3, an emerging cancer treatment target, Ubigene has its KO cell line in stock!

pubdate：2022-09-21

NLRP3, an emerging cancer treatment target, Ubigene has its KO cell line in stock! NLRP3 inflammasome...

[Research highlight] Ubigene provides CRISPR lentivirus to facilitate Non-invasive diagnosis of BLCA-

pubdate：2022-09-27

[Research highlight] Ubigene provides CRISPR lentivirus to facilitate Non-invasive diagnosis of BLCA ...

NLRP3, an emerging cancer treatment target, Ubigene has its KO cell line in stock!

pubdate：2022-09-21

NLRP3, an emerging cancer treatment target, Ubigene has its KO cell line in stock! NLRP3 inflammasome...